Edwards Lifesciences Corp
EW· NYSE
Edwards Lifesciences Corp
Orthopedic, prosthetic & surgical appliances & supplies29 peers
- Last sale
- Oct 1, 2026 · -1.40%
- Market cap
- $49.08B
- 576.4M shares
- Filings
- 1,064
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $6,067,600,000 | reported | |
| FY 2024 | 2024-12-31 | $5,439,500,000 | reported | |
| FY 2023 | 2023-12-31 | $5,010,000,000 | reported | |
| FY 2022 | 2022-12-31 | $4,464,000,000 | reported | |
| FY 2021 | 2021-12-31 | $5,232,500,000 | reported | |
| FY 2020 | 2020-12-31 | $4,386,300,000 | reported | |
| FY 2019 | 2019-12-31 | $4,348,000,000 | reported | |
| FY 2018 | 2018-12-31 | $3,722,800,000 | reported | |
| FY 2017 | 2017-12-31 | $3,435,300,000 | reported | |
| FY 2016 | 2016-12-31 | $2,963,700,000 | reported | |
| FY 2015 | 2015-12-31 | $2,493,700,000 | reported | |
| FY 2014 | 2014-12-31 | $2,322,900,000 | reported |
Edwards Lifesciences Corp · CIK 1099800 · Engraved from SEC EDGAR
